Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy
Priya Nigam
Despite a 50% gain, current valuation remains attractive; Petrobras' management mulls buybacks
The coworking space company is still dealing with the aftermath of the post-Adam Neumann era as cashflow is yet to come.